跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ESCITALOPRAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ESCITALOPRAM
Authorized
STANDARD
ESCITALOPRAM
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
23b5c5224b3fccca
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
23b5c5224b3fccca
Drug Approval Canada Name
ESCITALOPRAM
Product Name
ESCITALOPRAM
Status
Dormant
Status Date
2021-07-27
Original Market Date
2020-03-27
Din
02489171
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB10 ESCITALOPRAM
Atc Name
n 06 ab 10
Aig Number
0150435002
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
ESCITALOPRAM (ESCITALOPRAM OXALATE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
23b5c5224b3fccca
Type
Standard
Back to Health Canada Approvals